Evidence for a Causal Association Between Human Papillomavirus and a Subset of Head and Neck Cancers
The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Abstract
BACKGROUND: High-risk human papillomaviruses (HPVs) are etiologic agents for anogenital tract cancers and have been detected in head and neck squamous cell carcinomas (HNSCCs). We investigated, retrospectively, an etiologic role for HPVs in a large series of patients with HNSCC. METHODS: Tumor tissues from 253 patients with newly diagnosed or recurrent HNSCC were tested for the presence of HPV genome by use of polymerase chain reaction (PCR)-based assays, Southern blot hybridization, and in situ hybridization. The viral E6 coding region was sequenced to confirm the presence of tumor-specific viral isolates. Exons 5-9 of the TP53 gene were sequenced from 166 specimens. The hazard of death from HNSCC in patients with and without HPV-positive tumors was determined by proportional hazards regression analysis. RESULTS: HPV was detected in 62 (25%) of 253 cases (95% confidence interval [CI] = 19%-30%). High-risk, tumorigenic type HPV16 was identified in 90% of the HPV-positive tumors. HPV16 was localized specifically by in situ hybridization within the nuclei of cancer cells in preinvasive, invasive, and lymph node disease. Southern blot hybridization patterns were consistent with viral integration. Poor tumor grade (odds ratio [OR] = 2.4; 95% CI = 1.2- 4.9) and oropharyngeal site (OR = 6.2; 95% CI = 3.1-12.1) independently increased the probability of HPV presence. As compared with HPV-negative oropharyngeal cancers, HPV-positive oropharyngeal cancers were less likely to occur among moderate to heavy drinkers (OR = 0.17; 95% CI = 0.05-0.61) and smokers (OR = 0.16; 95% CI = 0.02-1.4), had a characteristic basaloid morphology (OR = 18.7; 95% CI = 2.1-167), were less likely to have TP53 mutations (OR = 0.06; 95% CI = 0.01-0. 36), and had improved disease-specific survival (hazard ratio [HR] = 0.26; 95% CI = 0.07-0.98). After adjustment for the presence of lymph node disease (HR = 2.3; 95% CI = 1.4- 3.8), heavy alcohol consumption (HR = 2.6; 95% CI = 1.4-4.7), and age greater than 60 years old (HR = 1.4; 95% CI = 0.8-2.3), all patients with HPV-positive tumors had a 59% reduction in risk of death from cancer when compared with HPV-negative HNSCC patients (HR = 0.41; 95% CI = 0.20-0.88). CONCLUSIONS: These data extend recent molecular and epidemiologic studies and strongly suggest that HPV-positive oropharyngeal cancers comprise a distinct molecular, clinical, and pathologic disease entity that is likely causally associated with HPV infection and that has a markedly improved prognosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_25 · Cited by 45,181
Regression Models and Life-Tables
Cox, D. R. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_37 · Cited by 26,297
Statistical Aspects of the Analysis of Data From Retrospective Studies of Disease
(1959) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/22.4.719 · Cited by 14,689
IARC Monographs on the Evaluation of Carcinogenic Risks to Humans
Zuckerman, A. J. (1995) · Journal of Clinical Pathology · doi:10.1136/jcp.48.7.691-a · Cited by 8,728
The environment and disease: association or causation?
Hill, A. B. (2015) · Journal of the Royal Society of Medicine · doi:10.1177/0141076814562718 · Cited by 7,285
Prevalence of Human Papillomavirus in Cervical Cancer: a Worldwide Perspective
Bosch, F. X., Manos, M. M., Munoz, N., Sherman, M., Jansen, A. M., Peto, J., Schiffman, M. H., Moreno, V., Kurman, R., Shan, K. V., et al. (1995) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/87.11.796 · Cited by 3,370
A general method for isolation of high molecular weight DNA from eukaryotes
Blin, N., & Stafford, D. W. (1976) · Nucleic Acids Research · doi:10.1093/nar/3.9.2303 · Cited by 2,770
The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53
Scheffner, M., Huibregtse, J. M., Vierstra, R. D., & Howley, P. M. (1993) · Cell · doi:10.1016/0092-8674(93)90384-3 · Cited by 2,054
Fluorescence detection in automated DNA sequence analysis
Smith, L. M., Sanders, J. Z., Kaiser, R. J., Hughes, P., Dodd, C., Connell, C. R., Heiner, C., Kent, S. B. H., & Hood, L. E. (1986) · Nature · doi:10.1038/321674a0 · Cited by 1,714
Structure and transcription of human papillomavirus sequences in cervical carcinoma cells
Schwarz, E., Freese, U. K., Gissmann, L., Mayer, W., Roggenbuck, B., Stremlau, A., & Hausen, H. Z. (1985) · Nature · doi:10.1038/314111a0 · Cited by 1,483
Genetic progression model for head and neck cancer: implications for field cancerization.
Califano, J. A., van der Riet, P., Westra, W. H., Nawroz, H., Clayman, G. L., Piantadosi, S., Corio, R. L., Lee, D. J., Greenberg, B. M., Koch, W. M., et al. (1996) · PubMed · Cited by 1,355
Münger, K., Werness, B. A., Dyson, N., Phelps, W. C., Harlow, E., & Howley, P. M. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb08594.x · Cited by 964
Identification of p53 Gene Mutations in Bladder Cancers and Urine Samples
Sidransky, D., Von Eschenbach, A., Tsai, Y. C., Jones, P., Summerhayes, I., Marshall, F., Paul, M., Green, P., Hamilton, S. R., Frost, P., et al. (1991) · Science · doi:10.1126/science.2024123 · Cited by 875
Baker, C. C., Phelps, W. C., Lindgren, V, Braun, M. J., Gonda, M. A., & Howley, P. M. (1987) · Journal of Virology · doi:10.1128/jvi.61.4.962-971.1987 · Cited by 757
Role of the p16 tumor suppressor gene in cancer.
Liggett, W. H., & Sidransky, D. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.3.1197 · Cited by 746
Persistence of Type-Specific Human Papillomavirus Infection among Cytologically Normal Women
Hildesheim, A., Schiffman, M. H., Gravitt, P. E., Glass, A. G., Greer, C. E., Zhang, T., Scott, D. R., Rush, B. B., Lawler, P., Sherman, M. E., et al. (1994) · Journal of Infectious Diseases · doi:10.1093/infdis/169.2.235 · Cited by 682
The incidence of p53 mutations increases with progression of head and neck cancer.
Boyle, J. O., Hakim, J., Koch, W. M., van der Riet, P., Hruban, R. H., Roa, R. A., Correo, R., Eby, Y. J., Ruppert, J. M., & Sidransky, D. (1993) · PubMed · Cited by 679
Presence and expression of human papillomavirus sequences in human cervical carcinoma cell lines.
Yee, C., Krishnan-Hewlett, I., Baker, C. C., Schlegel, R., & Howley, P. M. (1985) · PubMed · Cited by 677
High frequency of p16 (CDKN2/MTS-1/INK4A) inactivation in head and neck squamous cell carcinoma.
Reed, A. L., Califano, J. A., Cairns, P., Westra, W. H., Jones, R. M., Koch, W. M., Ahrendt, S. A., Eby, Y. J., Sewell, D. A., Nawroz, H., et al. (1996) · PubMed · Cited by 662
Oral Cancer Risk in Relation to Sexual History and Evidence of Human Papillomavirus Infection
Schwartz, S. M., Daling, J. R., Madeleine, M. M., Doody, D. R., Fitzgibbons, E. D., Wipf, G. C., Carter, J. J., Mao, E.-J., Huang, S., Beckmann, A. M., et al. (1998) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/90.21.1626 · Cited by 588
Franceschi, S., Talamini, R., Barra, S., Barón, A. E., Negri, E., Bidoli, E., Serraino, D., & Vecchia, C. L. (1990) · PubMed · Cited by 584
TP53 tumor suppressor gene: A model for investigating human mutagenesis
Fromentel, C. C. D., & Soussi, T. (1992) · Genes, Chromosomes and Cancer · doi:10.1002/gcc.2870040102 · Cited by 574
Cullen, A. P., Reid, R., Campion, M., & Lörincz, A. T. (1991) · Journal of Virology · doi:10.1128/jvi.65.2.606-612.1991 · Cited by 445
Human papillomavirus type 16 sequence variation in cervical cancers: a worldwide perspective
Yamada, T., Manos, M. M., Peto, J., Greer, C. E., Munoz, N., Bosch, F. X., & Wheeler, C. M. (1997) · Journal of Virology · doi:10.1128/jvi.71.3.2463-2472.1997 · Cited by 421
Tobacco smoking, alcohol drinking, and cancer of the oral cavity and oropharynx among U.S. veterans
Mashberg, A., Boffetta, P., Winkelman, R., & Garfinkel, L. (1993) · Cancer · doi:10.1002/1097-0142(19930815)72:4<1369::aid-cncr2820720436>3.0.co;2-l · Cited by 400
Paz, I. B., Cook, N., Odom-Maryon, T., Xie, Y., & Wilczynski, S. P. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19970201)79:3<595::aid-cncr24>3.0.co;2-y · Cited by 366
Loss of genes on the short arm of chromosome 11 in bladder cancer
Fearon, E. R., Feinberg, A. P., Hamilton, S. H., & Vogelstein, B. (1985) · Nature · doi:10.1038/318377a0 · Cited by 351
Viral etiology of juvenile- and adult-onset squamous papilloma of the larynx.
Mounts, P., Shah, K. V., & Kashima, H. K. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.17.5425 · Cited by 343
DETECTION AND TYPING OF GENITAL HUMAN PAPILLOMAVIRUSES
Ting, Y., & Manos, M. M. (1990) · PCR Protocols · doi:10.1016/b978-0-12-372180-8.50046-9 · Cited by 313
Hainaut, P., Soussi, T., Shomer, B., Hollstein, M., Greenblatt, M., Hovig, E., Harris, C. C., & Montesano, R. (1997) · Nucleic Acids Research · doi:10.1093/nar/25.1.151 · Cited by 298
Human papillomavirus types 16 and 18 sequences in carcinoma cell lines of the cervix
Pater, M. M., & Pater, A. (1985) · Virology · doi:10.1016/0042-6822(85)90164-3 · Cited by 271
Zehbe, I., Wilander, E., Delius, H., & Tommasino, M. (1998) · PubMed · Cited by 267
Wilczynski, S. P., Lin, B. T.-Y., Xie, Y., & Paz, I. B. (1998) · Europe PMC (PubMed Central) · Cited by 237
Yamada, T., Wheeler, C. M., Halpern, A. L., Stewart, A. C., Hildesheim, A., & Jenison, S. A. (1995) · Journal of Virology · doi:10.1128/jvi.69.12.7743-7753.1995 · Cited by 224
Xi, L. F., Koutsky, L. A., Galloway, D. A., Kiviat, N. B., Kuypers, J., Hughes, J. P., Wheeler, C. M., & Holmes, K. K. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.11.796 · Cited by 223
Statistical analysis of molecular epidemiology studies employing case-series.
Begg, C. B., & Zhang, Z. (1994) · PubMed · Cited by 215
Human papillomavirus and risk of oral cancer
Smith, E. M., Hoffman, H. T., Summersgill, K. S., Kirchner, H. L., Turek, L. P., & Haugen, T. H. (1998) · The Laryngoscope · doi:10.1097/00005537-199807000-00027 · Cited by 205
Matsukura, T., Koi, S., & Sugase, M. (1989) · Virology · doi:10.1016/0042-6822(89)90107-4 · Cited by 188
Snijders, P. J. F., Cromme, F. V., Van Brule, A. J. C. D., Schrijnemakers, H. F. J., Snow, G. B., Meijer, C. J. L. M., & Walboomers, J. M. M. (1992) · International Journal of Cancer · doi:10.1002/ijc.2910510602 · Cited by 179
Cubilla, A. L., Reuter, V. E., Gregoire, L., Ayala, G., Ocampos, S., Lancaster, W. D., & Fair, W. (1998) · The American Journal of Surgical Pathology · doi:10.1097/00000478-199806000-00014 · Cited by 169
Low risk of perinatal transmission of human papillomavirus: Results from a prospective cohort study
Heather Watts, D., Koutsky, L. A., Holmes, K. K., Goldman, D., Kuypers, J., Kiviat, N. B., & Galloway, D. A. (1998) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(98)80027-6 · Cited by 158
Gillison, M. L., Koch, W. M., & Shah, K. V. (1999) · Current Opinion in Oncology · doi:10.1097/00001622-199905000-00010 · Cited by 156
Self-citationStöppler, M. C., Ching, K., Stöppler, H., Clancy, K., Schlegel, R., & Icenogle, J. (1996) · Journal of Virology · doi:10.1128/jvi.70.10.6987-6993.1996 · Cited by 152
Jones, D. L., & Münger, K. (1997) · Journal of Virology · doi:10.1128/jvi.71.4.2905-2912.1997 · Cited by 146
Human papillomavirus in a necessary cause of invasive cervical cancer worldwide
(1999) · Pure Amsterdam UMC · doi:10.1002/(sici)1096-9896(199909)189:1 · Cited by 140
Human Papillomavirus in Head and Neck Squamous Cell Carcinomas in Nonsmokers
Fouret, P. J., Monceaux, G., Temam, S., Lacourreye, L., & Guily, J. L. S. (1997) · Archives of Otolaryngology - Head and Neck Surgery · doi:10.1001/archotol.1997.01900050063008 · Cited by 137
Steenbergen, R. D. M., Hermsen, M. A. J. A., Walboomers, J. M. M., Joenje, H., Arwert, F., Meijer, C. J. L. M., & Snijders, P. J. F. (1995) · PubMed · Cited by 127
Song, S., Gulliver, G. A., & Lambert, P. F. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.5.2290 · Cited by 115
Kellokoski, J. K., Syrjänen, S., Chang, F., Yliskoski, M. H., & Syrjänen, K. J. (1992) · Journal of Oral Pathology and Medicine · doi:10.1111/j.1600-0714.1992.tb00975.x · Cited by 113
Immortalization and Transformation of Human Cells by Human Papillomavirus
McDougall, J. K. (1994) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-78487-3_6 · Cited by 111
Risk of anal carcinoma in situ in relation to human papillomavirus type 16 variants.
Xi, L., Critchlow, C. W., Wheeler, C. M., Koutsky, L. A., Galloway, D. A., Kuypers, J. M., Hughes, J. P., Hawes, S. E., Surawicz, C. M., Goldbaum, G. M., et al. (1998) · PubMed · Cited by 106
The papillomavirus E6 proteins
Rapp, L., & Chen, J. J. (1998) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(98)00009-2 · Cited by 104
A possible role for human papillomaviruses in head and neck cancer
Steinberg, B. M., & DiLorenzo, T. P. (1996) · Cancer and Metastasis Reviews · doi:10.1007/bf00049489 · Cited by 98
DeWeese, T. L., Walsh, J. C., Dillehay, L. E., Kessis, T. D., Hedrick, L., Cho, K. R., & Nelson, W. G. (1997) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(96)00448-8 · Cited by 84
An association of HPV 16 with squamous cell carcinoma of Waldeyer's tonsillar ring
Tideman, H. (1999) · International Journal of Oral and Maxillofacial Surgery · doi:10.1016/s0901-5027(99)80213-6 · Cited by 83
HPV Prevalence among Mexican Women with Neoplastic and Normal Cervixes
Torroella‐Kouri, M., Morsberger, S., Carrillo, A., Mohar, A., Meneses, A., Ibarra, M., Daniel, R. W., Ghaffari, A. M., Solorza, G., & Shah, K. V. (1998) · Gynecologic Oncology · doi:10.1006/gyno.1998.5055 · Cited by 81
Interaction of HPV-18 and nitrosomethylurea in the induction of squamous cell carcinoma
Garrett, L. R., Perez‐Reyes, N., Smith, P. P., & McDougall, J. K. (1993) · Carcinogenesis · doi:10.1093/carcin/14.2.329 · Cited by 59
Shnitman Magal, S., Jackman, A., Pei, X. F., Schlegel, R., & Sherman, L. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19980105)75:1<96::aid-ijc15>3.0.co;2-b · Cited by 51
HPV-16 oncogenes E6 and E7 are mutagenic in normal human oral keratinocytes
Liu, X., Han, S., Baluda, M. A., & Park, N. (1997) · Oncogene · doi:10.1038/sj.onc.1201078 · Cited by 47
Kahn, T., Turazza, E., Ojeda, R., Bercovich, A., Stremlau, A., Lichter, P., Poustka, A., Grinstein, S., & Hausen, H. Z. (1994) · PubMed · Cited by 43
Gardiol, D., & Banks, L. (1998) · Journal of General Virology · doi:10.1099/0022-1317-79-8-1963 · Cited by 22
Cited by
Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer
Ang, K. K., Harris, J., Wheeler, R., Weber, R., Rosenthal, D. I., Nguyen-Tân, P. F., Westra, W. H., Chung, C. H., Jordan, R. C., Lu, C., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0912217 · Cited by 6,566
Self-citationPushko, P., Pumpens, P., & Grens, E. (2013) · Intervirology · doi:10.1159/000346773 · Cited by 5,950
Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy
Topalian, S. L., Taube, J. M., Anders, R. A., & Pardoll, D. M. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.36 · Cited by 2,733
Fakhry, C., Westra, W. H., Li, S., Cmelak, A., Ridge, J. A., Pinto, H., Forastiere, A., & Gillison, M. L. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn011 · Cited by 2,779
Self-citationCase–Control Study of Human Papillomavirus and Oropharyngeal Cancer
D'Souza, G., Kreimer, A. R., Viscidi, R., Pawlita, M., Fakhry, C., Koch, W. M., Westra, W. H., & Gillison, M. L. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa065497 · Cited by 2,692
Self-citation
Metadata
- Authors
- Gillison, M. L.
- Venue
- Journal of the National Cancer Institute
- Publisher
- Oxford University Press (OUP)
- Published
- 2000-05-03
- Volume
- 92
- Issue
- 9
- Pages
- 709-720
- ISSN
- 0027-8874 (ISSN-L)
- 1460-2105
- OpenAlex
- W2149166037
- Cited by
- 3,101
- References
- 61
- FWCI
- 53.31
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.